Population-based study of first onset and chronicity in major depressive disorder

Research output: Contribution to journalArticle

Abstract

Context: There are no studies of the natural history of major depressive disorder that lack prevalence and clinic biases. Objectives: To estimate risk factors for first lifetime onset and parameters of chronicity following the first episode, including duration, recovery, and recurrence, and to search for predictors of each parameter. Design: Prospective population-based cohort study with 23 years of follow-up. Setting: East Baltimore, Maryland, an urban setting. Participants: Probability sample of 3481 adult household residents in 1981, including 92 with first lifetime onset of major depressive disorder during the course of the follow-up, and 1739 other participants followed up for at least 13 years. Outcome Measures: Diagnostic Interview Schedule and Life Chart Interview. Results: Female participants showed higher risk of onset of disorder, longer duration of episodes, and a nonsignificant tendency for higher risk of recurrence. Sex was not related to recovery. The median episode length was 12 weeks. About 15% of 92 individuals with first episodes did not have a year free of episodes, even after 23 years. About 50% of first episode participants recovered and had no future episodes. The evolution of the course was relatively stable from first to later episodes. Individuals with 1 or 2 short alleles of the serotonin transporter gene were at higher risk for an initial episode, but experienced episodes of shorter duration. There were few strong predictors of recovery or recurrence. Conclusions: Major depressive disorder is unremitting in 15% of cases and recurrent in 35%. About half of those with a first-onset episode recover and have no further episodes.

Original languageEnglish (US)
Pages (from-to)513-520
Number of pages8
JournalArchives of General Psychiatry
Volume65
Issue number5
DOIs
StatePublished - May 2008

Fingerprint

Major Depressive Disorder
Recurrence
Interviews
Population
Sampling Studies
Serotonin Plasma Membrane Transport Proteins
Baltimore
Appointments and Schedules
Cohort Studies
Alleles
Outcome Assessment (Health Care)
Genes

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Population-based study of first onset and chronicity in major depressive disorder. / Eaton, William W; Shao, Huibo; Nestadt, Gerald; Lee, Ben Hochang; Bienvenu, Oscar J; Zandi, Peter P.

In: Archives of General Psychiatry, Vol. 65, No. 5, 05.2008, p. 513-520.

Research output: Contribution to journalArticle

@article{9c499c3f61e042da8146619eacb8885f,
title = "Population-based study of first onset and chronicity in major depressive disorder",
abstract = "Context: There are no studies of the natural history of major depressive disorder that lack prevalence and clinic biases. Objectives: To estimate risk factors for first lifetime onset and parameters of chronicity following the first episode, including duration, recovery, and recurrence, and to search for predictors of each parameter. Design: Prospective population-based cohort study with 23 years of follow-up. Setting: East Baltimore, Maryland, an urban setting. Participants: Probability sample of 3481 adult household residents in 1981, including 92 with first lifetime onset of major depressive disorder during the course of the follow-up, and 1739 other participants followed up for at least 13 years. Outcome Measures: Diagnostic Interview Schedule and Life Chart Interview. Results: Female participants showed higher risk of onset of disorder, longer duration of episodes, and a nonsignificant tendency for higher risk of recurrence. Sex was not related to recovery. The median episode length was 12 weeks. About 15{\%} of 92 individuals with first episodes did not have a year free of episodes, even after 23 years. About 50{\%} of first episode participants recovered and had no future episodes. The evolution of the course was relatively stable from first to later episodes. Individuals with 1 or 2 short alleles of the serotonin transporter gene were at higher risk for an initial episode, but experienced episodes of shorter duration. There were few strong predictors of recovery or recurrence. Conclusions: Major depressive disorder is unremitting in 15{\%} of cases and recurrent in 35{\%}. About half of those with a first-onset episode recover and have no further episodes.",
author = "Eaton, {William W} and Huibo Shao and Gerald Nestadt and Lee, {Ben Hochang} and Bienvenu, {Oscar J} and Zandi, {Peter P}",
year = "2008",
month = "5",
doi = "10.1001/archpsyc.65.5.513",
language = "English (US)",
volume = "65",
pages = "513--520",
journal = "JAMA Psychiatry",
issn = "2168-622X",
publisher = "American Medical Association",
number = "5",

}

TY - JOUR

T1 - Population-based study of first onset and chronicity in major depressive disorder

AU - Eaton, William W

AU - Shao, Huibo

AU - Nestadt, Gerald

AU - Lee, Ben Hochang

AU - Bienvenu, Oscar J

AU - Zandi, Peter P

PY - 2008/5

Y1 - 2008/5

N2 - Context: There are no studies of the natural history of major depressive disorder that lack prevalence and clinic biases. Objectives: To estimate risk factors for first lifetime onset and parameters of chronicity following the first episode, including duration, recovery, and recurrence, and to search for predictors of each parameter. Design: Prospective population-based cohort study with 23 years of follow-up. Setting: East Baltimore, Maryland, an urban setting. Participants: Probability sample of 3481 adult household residents in 1981, including 92 with first lifetime onset of major depressive disorder during the course of the follow-up, and 1739 other participants followed up for at least 13 years. Outcome Measures: Diagnostic Interview Schedule and Life Chart Interview. Results: Female participants showed higher risk of onset of disorder, longer duration of episodes, and a nonsignificant tendency for higher risk of recurrence. Sex was not related to recovery. The median episode length was 12 weeks. About 15% of 92 individuals with first episodes did not have a year free of episodes, even after 23 years. About 50% of first episode participants recovered and had no future episodes. The evolution of the course was relatively stable from first to later episodes. Individuals with 1 or 2 short alleles of the serotonin transporter gene were at higher risk for an initial episode, but experienced episodes of shorter duration. There were few strong predictors of recovery or recurrence. Conclusions: Major depressive disorder is unremitting in 15% of cases and recurrent in 35%. About half of those with a first-onset episode recover and have no further episodes.

AB - Context: There are no studies of the natural history of major depressive disorder that lack prevalence and clinic biases. Objectives: To estimate risk factors for first lifetime onset and parameters of chronicity following the first episode, including duration, recovery, and recurrence, and to search for predictors of each parameter. Design: Prospective population-based cohort study with 23 years of follow-up. Setting: East Baltimore, Maryland, an urban setting. Participants: Probability sample of 3481 adult household residents in 1981, including 92 with first lifetime onset of major depressive disorder during the course of the follow-up, and 1739 other participants followed up for at least 13 years. Outcome Measures: Diagnostic Interview Schedule and Life Chart Interview. Results: Female participants showed higher risk of onset of disorder, longer duration of episodes, and a nonsignificant tendency for higher risk of recurrence. Sex was not related to recovery. The median episode length was 12 weeks. About 15% of 92 individuals with first episodes did not have a year free of episodes, even after 23 years. About 50% of first episode participants recovered and had no future episodes. The evolution of the course was relatively stable from first to later episodes. Individuals with 1 or 2 short alleles of the serotonin transporter gene were at higher risk for an initial episode, but experienced episodes of shorter duration. There were few strong predictors of recovery or recurrence. Conclusions: Major depressive disorder is unremitting in 15% of cases and recurrent in 35%. About half of those with a first-onset episode recover and have no further episodes.

UR - http://www.scopus.com/inward/record.url?scp=43149091691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43149091691&partnerID=8YFLogxK

U2 - 10.1001/archpsyc.65.5.513

DO - 10.1001/archpsyc.65.5.513

M3 - Article

VL - 65

SP - 513

EP - 520

JO - JAMA Psychiatry

JF - JAMA Psychiatry

SN - 2168-622X

IS - 5

ER -